Incrementum provides senior-led support for the establishment of pharmaceutical companies within the UK, ensuring that regulatory, commercial and operational elements are aligned from the outset. The focus is not simply on forming a legal entity, but on creating a business that can operate effectively within NHS structures.

Support covers the full set-up process, including company formation, banking and operational infrastructure, alongside guidance on WDA(H) readiness and marketing authorisation strategy. These elements are developed in parallel with a clear commercial objective, ensuring that early decisions support long-term market engagement.

Supply chain design is an integral part of the approach, including importation models, QP release and distribution strategy including choice of 3PL provider. This ensures that operations are compliant, scalable and aligned with NHS procurement expectations from day one.

A central advantage is the practical understanding of how the UK system works in reality. Company set-up is undertaken with a clear view of procurement dynamics, stakeholder behaviour and supply requirements, enabling new entrants to engage credibly with the NHS.

The outcome is a fully aligned, operational business, not just a registered entity, ready to function effectively within the UK pharmaceutical market.